Origgi is joining Valo Therapeutics as CEO after four years at investment unit Johnson and Johnson Innovation,

Sharma is moving to Dubai for a position in VC.

His background includes roles in strategy consulting, early-stage companies, venture capital and pharmaceuticals.

Climate tech investors attracted to the US by the Inflation Reduction Act climate bill are now turning their eyes back to Europe.

After five years as president of Stanley Black & Decker's corporate VC fund, Dina Routhier has moved to the newly formed Teradyne Robotics Ventures.

Oliver Schmäschke will head the German telecoms company's investment arm T.Capital.

The hire is part of its goal to strengthen its presence in the biotech sector and expand its international investment platform.

eToro, Klarna and Circle have reportedly all suspended work on their initial public offerings, leaving corporate backers waiting longer for exits.

The launch of the fund follows Sanofi’s investment in a $1bn insulin production facility in Beijing, China.

The language may be changing but the opportunities and the returns are still there for impact investors.